|4May 31, 3:24 PM ET

Guse Kyle 4

4 · ATOSSA GENETICS INC · Filed May 31, 2018

Insider Transaction Report

Form 4
Period: 2018-05-30
Guse Kyle
CFO & General Counsel
Transactions
  • Purchase

    Warrants

    2018-05-30$1000.00/sh+2,272$2,272,0002,272 total
    Exercise: $4.05From: 2018-05-30Exp: 2022-05-30Common Stock (2,272 underlying)
  • Purchase

    Series B Convertible Preferred Stock

    2018-05-30$1000.00/sh+8$8,0008 total
    Exercise: $3.52From: 2018-05-30Common Stock (2,273 underlying)
Footnotes (4)
  • [F1]Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52.
  • [F2]Shares of Series B Convertible Preferred Stock do not expire.
  • [F3]No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share.
  • [F4]Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants.

Documents

1 file
  • 4
    s110545_form4.xmlPrimary

    OWNERSHIP DOCUMENT